Literature DB >> 16274505

The importance of Campylobacter coli in human campylobacteriosis: prevalence and genetic characterization.

M Gürtler1, T Alter, S Kasimir, K Fehlhaber.   

Abstract

The primary aim of this study was to detect and genotype Campylobacter coli strains from humans over a period of one year from November 2002 to October 2003. Campylobacter spp. were isolated from patients with symptoms of enteric infection. Amplified fragment length polymorphism (AFLP) analysis was used to identify the genetic diversity of C. coli strains by cluster analysis. A total of 18.6% of all Campylobacter isolates were identified as C. coli. These data show, that C. coli is indeed of importance to human campylobacter infections. Heterogeneous patterns were detectable among the human C. coli pool by AFLP analysis suggesting different sources of infection. A continuous seasonal shift of genotypes was detectable.

Entities:  

Mesh:

Year:  2005        PMID: 16274505      PMCID: PMC2870342          DOI: 10.1017/S0950268805004164

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Longitudinal study of the persistence of antimicrobial-resistant campylobacter strains in distinct Swine production systems on farms, at slaughter, and in the environment.

Authors:  Macarena P Quintana-Hayashi; Siddhartha Thakur
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  The absence of intervening sequences in 23S rRNA genes of Campylobacter coli isolates from Turkeys is a unique attribute of a cluster of related strains which also lack resistance to erythromycin.

Authors:  Kamfai Chan; William G Miller; Robert E Mandrell; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2006-12-22       Impact factor: 4.792

Review 4.  The clinical importance of emerging Campylobacter species.

Authors:  Si Ming Man
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

5.  Large Sequence Diversity within the Biosynthesis Locus and Common Biochemical Features of Campylobacter coli Lipooligosaccharides.

Authors:  Alejandra Culebro; Joana Revez; Ben Pascoe; Yasmin Friedmann; Matthew D Hitchings; Jacek Stupak; Samuel K Sheppard; Jianjun Li; Mirko Rossi
Journal:  J Bacteriol       Date:  2016-09-22       Impact factor: 3.490

6.  Updating the genomic taxonomy and epidemiology of Campylobacter hyointestinalis.

Authors:  David A Wilkinson; Andrew J O'Donnell; Rukhshana N Akhter; Ahmed Fayaz; Hamish J Mack; Lynn E Rogers; Patrick J Biggs; Nigel P French; Anne C Midwinter
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

7.  Extending statistical models for source attribution of zoonotic diseases: a study of campylobacteriosis.

Authors:  Sih-Jing Liao; Jonathan Marshall; Martin L Hazelton; Nigel P French
Journal:  J R Soc Interface       Date:  2019-01-31       Impact factor: 4.118

8.  Phylogenetic analysis reveals common antimicrobial resistant Campylobacter coli population in antimicrobial-free (ABF) and commercial swine systems.

Authors:  Macarena P Quintana-Hayashi; Siddhartha Thakur
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

9.  Prevalence of Campylobacter spp. in skinless, boneless retail broiler meat from 2005 through 2011 in Alabama, USA.

Authors:  Aretha Williams; Omar A Oyarzabal
Journal:  BMC Microbiol       Date:  2012-08-24       Impact factor: 3.605

10.  Genomic evidence for the emergence and evolution of pathogenicity and niche preferences in the genus Campylobacter.

Authors:  Gregorio Iraola; Ruben Pérez; Hugo Naya; Fernando Paolicchi; Eugenia Pastor; Sebastián Valenzuela; Lucía Calleros; Alejandra Velilla; Martín Hernández; Claudia Morsella
Journal:  Genome Biol Evol       Date:  2014-09-04       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.